iPS Differentiation

 

DefiniGEN’s iPS Differentiation service utilizes our proprietary OptiDIFF platform to generate high functionality terminally differentiated custom cell products to fit client specifications. The OptiDIFF platform was developed from world-leading research undertaken at the University of Cambridge and has been demonstrated on a range of cell types. The client  receives fully differentiated rigorously QCed cell products which are genotype and phenotype verified in a highly relevant physiological background.